US FDA grants full approval to AbbVie's ovarian cancer therapy
(Source: Reuters: Health)
Source: Reuters: Health - March 23, 2024 Category: Consumer Health News Source Type: news
U.S. Food and Drug Administration (FDA) Grants Full Approval for Elahere (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
The full approval of Elahere is based on the confirmatory MIRASOL Phase 3 trial that supports the medicine as a potential new standard of care for folate receptor alpha (FRα)-positive, platinum-resistant ovarian cancer (PROC)
Data show that... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 22, 2024 Category: Drugs & Pharmacology Source Type: news
Predicting Risk for Secondary Leukemia after PARPi Therapy Predicting Risk for Secondary Leukemia after PARPi Therapy
A new study pinpointed potential predictive factors for secondary myelodysplastic syndrome or acute myeloid leukemia after PARP inhibitor therapy in women with ovarian cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Reducing the side effects of breast and ovarian cancer treatment
Some anti-cancer treatments not only target tumour cells but also healthy cells. If their effects on the latter are too strong, their use can become limiting. A team from the University of Geneva (UNIGE), in collaboration with Basel-based FoRx Therapeutics, has identified the mechanism of action of PARP inhibitors, used in particular for breast and ovarian cancer in patients carrying the BRCA gene mutation. (Source: World Pharma News)
Source: World Pharma News - March 22, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
The U.S. bans most common form of asbestos, after decades of pushback from industry
More than 50 other countries have already banned the substance, which has been known to lead to lung and ovarian cancer, mesothelioma and other deadly illnesses.(Image credit: Jenny Evans) (Source: NPR Health and Science)
Source: NPR Health and Science - March 18, 2024 Category: Consumer Health News Authors: Joe Hernandez Source Type: news
Debate Arises Over Ovarian Tissue Transplants to Menopause Debate Arises Over Ovarian Tissue Transplants to Menopause
Researchers say a treatment used for cancer patients can delay the onset of menopause significantly for healthy women, but others in the field question the safety and ethics of the procedure.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 18, 2024 Category: Transplant Surgery Tags: Ob/Gyn & Women ' s Health Source Type: news
Using Ovarian Tissue Transplantation to Delay Menopause Using Ovarian Tissue Transplantation to Delay Menopause
Researchers say a treatment used for cancer patients can delay the onset of menopause significantly for healthy women, but others in the field question the safety and ethics of the procedure.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 18, 2024 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Source Type: news
Raludotatug Deruxtecan Promising in Platinum-Resistant Advanced Ovarian Cancer
(MedPage Today) -- SAN DIEGO -- Treatment with raludotatug deruxtecan (R-DXd) led to an "exciting" response rate among patients with heavily pretreated, platinum-resistant advanced ovarian cancer, according to an early-phase trial.
In a subgroup... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 17, 2024 Category: Hematology Source Type: news
FL Jury Fails to Agree on J & J Talc Verdict
Bob Sugarman sued Johnson & Johnson, claiming the company’s talc products caused the death of his wife, Marilyn Seskin, MD. The case has ended in a mistrial after the jury was unable to agree on a verdict.
The jury note the judge read aloud in court stated: “We are hopelessly deadlocked with absolutely, positively no way to resolve it.”
The closely watched trial was held in Florida’s Circuit Court for the 11th Judicial Circuit in Miami-Dade County. It was the first talc powder trial against J&J in 3 years after litigation had been paused during the company’s failed bankruptcy proceedings...
Source: Asbestos and Mesothelioma News - March 11, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos Exposure Companies johnson Lawsuit Legal talc Talcum Powder Verdict Source Type: news
FL Senate Approves Bill Requiring Form for Asbestos Lawsuits
The Florida Senate voted to approve Republican Senator Travis Hutson’s proposed SB 720 requiring courts to dismiss asbestos claims without a completed information form. The bill’s next stop is the Florida House of Representatives.
If the House approves the measure, it would then go before the governor. If signed into law, those with asbestos-related diseases will have to provide more extensive information when filing a lawsuit.
SB 720 has the backing of businesses. Lobbying groups including the U.S. Chamber of Commerce and the Florida Insurance Council also support the measure.
However, veterans groups a...
Source: Asbestos and Mesothelioma News - March 11, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos (general) Asbestos Exposure Asbestosis Cancer (Non-Meso) Florida Legal Lawsuit Mesothelioma Source Type: news
Dr Google will see you now! Women diagnosed with ovarian cancer look up tell-tale symptoms of deadly disease a YEAR before being diagnosed
Women battling the disease looked up symptoms including weight loss , bladder problems and bloating up to 360 days before being referred to a specialist. (Source: the Mail online | Health)
Source: the Mail online | Health - March 11, 2024 Category: Consumer Health News Source Type: news
CEUS shines in diagnostic, interventional settings
Dynamic contrast-enhanced ultrasound (CEUS) is a useful tool for interventions, according to a March 3 presentation given at ECR 2024. In his talk, Dean Huang, MD, from King’s College London in England outlined novel applications for CEUS in vascular and nonvascular imaging, as well as therapeutic and potential future applications. “Ultrasound contrast agent use can be ubiquitous in interventional practice and can solve many logistical or clinical diagnostic problems,” he said. “And we can achieve all of this without the use of radiation and nephrotoxicity.” Dean Huang, MD, from King's College London highligh...
Source: AuntMinnie.com Headlines - March 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
The First Over-the-Counter Birth Control Pill Is Here
The first birth control pill that people can buy without a prescription, called Opill, is shipping to stores this week.
Perrigo, the Ireland-based company that makes Opill, said the pills should be available to purchase at retail pharmacies and online by the end of March. The pills are designed to be taken daily at about the same time each day, and they will be sold in one-month packs for $19.99 and three-month packs for $49.99.
[time-brightcove not-tgx=”true”]
A spokesperson for CVS, one pharmacy that will be stocking the pill, said the pills will be in more than 7,500 of its stores nationwide and will ...
Source: TIME: Health - March 4, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
ECR: What makes small ovarian lesions light up like a lightbulb?
Research presented at ECR 2024 suggests that diffusion-weighted MRI (DW-MRI) has value in ovarian cancer treatment planning.
In his talk, Max Lahaye, MD, PhD, from the Netherlands Cancer Institute in Amsterdam discussed his team's findings which showed that DW-MRI could perform a complete primary and interval debulking with high accuracy.Max Lahaye, MD, of the Netherlands Cancer Institute in Amsterdam presents findings on the clinical impact of dedicated MR staging of ovarian cancer patients during ECR 2024.
The Netherlands Cancer Institute, Leiden University Medical Center, and Catharina Ziekenhuis Teaching Hospital ar...
Source: AuntMinnie.com Headlines - March 4, 2024 Category: Radiology Authors: Liz Carey Tags: MRI Womens Imaging Ob/Gyn Source Type: news
Cancer Prevention Strategies Linked to Mortality Reduction in BRCA Carriers
(MedPage Today) -- Risk management strategies including bilateral salpingo-oophorectomy (BSO) for ovarian cancer and MRI surveillance for breast cancer were associated with a significant reduction in mortality for women with BRCA1/2 sequence variations... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 29, 2024 Category: Hematology Source Type: news
